Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 354,693Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Cipla

02 3Novartis Pharmaceuticals Australia Pty Limited

03 8Novartis Pharmaceuticals Corporation

04 2Novartis South Africa (Pty) Ltd

05 3RICONPHARMA LLC

06 3XYZ Pharma

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

SIPONIMOD

Brand Name : MAYZENT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 0.25MG BASE

Packaging :

Approval Date : 2019-03-26

Application Number : 209884

Regulatory Info : RX

Registration Country : USA

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

SIPONIMOD

Brand Name : MAYZENT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2MG BASE

Packaging :

Approval Date : 2019-03-26

Application Number : 209884

Regulatory Info : RX

Registration Country : USA

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

SIPONIMOD

Brand Name : MAYZENT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 2021-08-24

Application Number : 209884

Regulatory Info : RX

Registration Country : USA

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

In Any Case

Brand Name : Mayzent

Dosage Form : Film Coated Tablet

Dosage Strength : 0.25mg

Packaging :

Approval Date : 22/10/2020

Application Number : 67230

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

In Any Case

Brand Name : Mayzent

Dosage Form : Film Coated Tablet

Dosage Strength : 2mg

Packaging :

Approval Date : 22/10/2020

Application Number : 67230

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

In Any Case

Brand Name : Mayzent

Dosage Form : Film Coated Tablet

Dosage Strength : 1mg

Packaging :

Approval Date : 22/10/2020

Application Number : 67230

Regulatory Info : Allowed

Registration Country : Switzerland

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

SIPONIMOD

Brand Name : MAYZENT

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging :

Approval Date :

Application Number : 2496429

Regulatory Info : Prescription

Registration Country : Canada

blank

11

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

SIPONIMOD

Brand Name : MAYZENT

Dosage Form : TABLET

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number : 2496437

Regulatory Info : Prescription

Registration Country : Canada

blank

12

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

SIPONIMOD

Brand Name : SIPONIMOD

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 0.25MG BASE

Packaging :

Approval Date : 2025-04-22

Application Number : 218444

Regulatory Info : DISCN

Registration Country : USA

blank

13

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

SIPONIMOD

Brand Name : SIPONIMOD

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 2025-04-22

Application Number : 218444

Regulatory Info : DISCN

Registration Country : USA

blank

14

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

SIPONIMOD

Brand Name : SIPONIMOD

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2MG BASE

Packaging :

Approval Date : 2025-04-22

Application Number : 218444

Regulatory Info : DISCN

Registration Country : USA

blank

15

XYZ Pharma

Aus. Peptide Conference
Not Confirmed
arrow

XYZ Pharma

arrow
Aus. Peptide Conference
Not Confirmed

SIPONIMOD

Brand Name : SIPONIMOD

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging :

Approval Date :

Application Number : 218393

Regulatory Info :

Registration Country : USA

blank

16

XYZ Pharma

Aus. Peptide Conference
Not Confirmed
arrow

XYZ Pharma

arrow
Aus. Peptide Conference
Not Confirmed

SIPONIMOD

Brand Name : SIPONIMOD

Dosage Form : TABLET

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number : 218393

Regulatory Info :

Registration Country : USA

blank

17

XYZ Pharma

Aus. Peptide Conference
Not Confirmed
arrow

XYZ Pharma

arrow
Aus. Peptide Conference
Not Confirmed

SIPONIMOD

Brand Name : SIPONIMOD

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number : 218393

Regulatory Info :

Registration Country : USA

blank

18

Novartis South Africa (Pty) Ltd

Country
Aus. Peptide Conference
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
Aus. Peptide Conference
Not Confirmed

Siponimod

Brand Name : Kiendra

Dosage Form : TAB

Dosage Strength : 0.25mg

Packaging : 12X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

19

Novartis South Africa (Pty) Ltd

Country
Aus. Peptide Conference
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
Aus. Peptide Conference
Not Confirmed

Siponimod

Brand Name : Kiendra

Dosage Form : TAB

Dosage Strength : 2mg

Packaging : 28X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

20

Novartis Pharmaceuticals Australia ...

Country
Aus. Peptide Conference
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
Aus. Peptide Conference
Not Confirmed

Siponimod

Brand Name : Mayzent

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank